Recent studies show that the chemokine receptor CCR7 helps T lymphocytes and dendritic cells to navigate into the T-cell zone of lymphoid organs. Furthermore, downmodulation of CCR7 redirects some activated T cells from these zones into other lymphoid tissue compartments.
Most adaptive immune responses are initiated when antigen-specific T cells encounter antigen-bearing dendritic cells inside secondary lymphoid organs. As the frequency of T cells specific for any given antigen is very low, it is important that individual dendritic cells can easily meet with many potential T-cell suitors. This is achieved by the colocalization of dendritic cells and T cells in specific regions of lymph nodes and the spleen known as T zones, which can be thought of as meeting places for T cells and dendritic cells. After entering the lymph nodes or spleen, T cells migrate through the T zone and search out dendritic cells. Similarly, entering dendritic cells migrate quickly into the depths of the T zone and contact multiple T cells. Even without knowing more than this, one might speculate that the cells are coming together by responding to the same attractive cues. Yet, while much has been learnt about how cells leave the blood and enter the lymphoid organs [1] , little was known until recently about which signals directed cells into the T zone. Rapid progress has now clearly shown that the chemokine receptor CCR7 and its chemokine ligands recruit lymphocytes and dendritic cells into lymphoid T zones [2, 3] . Naïve T cells -that is, those that have not yet responded to antigen -enter the lymph nodes from the blood across high endothelial venules while antigenbearing dendritic cells enter predominantly by afferent lymphatic vessels (Figure 1 ). In the spleen, both cell types enter from the blood. The mechanism of cell migration to the T zones of these lymphoid organs began to unfold with the discovery of two chemokines of the C-C class that are efficacious attractants of naïve T cells. Termed SLC/6Ckine/Exodus2/TCA4 and ELC/MIP3β/CKβ-11 (hereafter SLC and ELC, respectively), their genes colocalize on mouse chromosome 4 and they are more related to each other than to other chemokines [4, 5] . SLC differs from ELC, however, in that it contains an additional 30 amino acid domain at the carboxyl terminus that is highly basic. SLC is produced by high endothelial venules and by stromal cells distributed through T zones [5] . ELC is also expressed in cells throughout the T zone but does not appear to be produced by high endothelial venules [5] . During its primary characterization, ELC had been identified as a ligand for CCR7, and subsequently SLC was also found to bind this receptor [4, 5] .
The next important development in SLC/ELC biology was the discovery of a spontaneous mutant mouse line that lacked measurable levels of SLC expression in lymphoid tissue [2] . ELC could still be detected, but at levels several-fold below those found in normal mice [2] . This mutant line had been named plt, for paucity of lymph node T cells, and had been shown to have greatly reduced migration of T cells into lymph nodes and Peyer's patches, the regions of lymphoid tissue in the small intestine [6] . T cells also did not accumulate in the white pulp of spleen where lymphocytes are normally located, instead appearing around the sinuses in the red pulp where red blood cells are usually found. Genetic mapping studies placed the plt locus in the same region of chromosome 4 as the genes for SLC and ELC, but the genetic analysis turned out to be complex and initially no mutation of SLC was found [2, 6 ].
An explanation is now in hand with the discovery that there are two genes encoding mouse SLC [7] . The identified genes encode proteins differing by only two amino acids and the two forms appear to have equivalent activity, consistent with the fact that only one sequence for SLC has been identified in humans [7] . But the two mouse genes differ in their expression pattern: one is expressed at high levels in lymphoid organs, including high endothelial venules, and this is the gene deleted in plt mice [7] ; the second is expressed predominantly in non-lymphoid organs and continues to be expressed in plt mice. Since most of the SLC signal detected in non-lymphoid organs comes from lymphatic endothelium, it seems likely that the remaining SLC gene in plt animals is expressed at this site. What is still unclear is the size of the genomic deletion in the plt strain, and whether additional genes are lost.
Given the complexity of the plt locus, the characterization of CCR7-deficient mice has been keenly anticipated. The wait is now over, with a recent report in Cell describing mice with a targeted mutation of the CCR7 gene [3] . The first obvious question has been immediately answeredthe mice have a striking paucity of lymph node T cells [3] . When T cells from these CCR7-deficient mice are transferred to wild-type recipients, they home very poorly into bb10a08.qxd lymph nodes and Peyer's patches, indicating a defect in recruitment across high endothelial venules. Taken together with the constitutive production of SLC by high endothelial venules, the failure of T cells to home normally to lymph nodes in plt mice, and the ability of SLC to promote shear-resistant adhesion of T cells via integrin activation [8, 9] , it can be concluded that CCR7 and SLC are important for promoting integrin-mediated arrest of lymphocytes on high endothelial venules. Although a role for ELC in this process has not yet been excluded, it seems most likely that SLC has evolved to serve this function with the additional domain at the carboxyl terminus helping to tether the molecule to proteoglycans at the high endothelial venule surface (Figure 1 ).
Further examination of the lymphoid organs of the CCR7-deficient mice revealed additional defects. Within the lymph nodes of these mice, T cells are sparsely distributed and many cells are mislocated near the subcapsular sinus around the edge of the lymph node, or in areas normally occupied by B cells [3] . In the spleen, T cells continue to accumulate but they largely fail to enter the T-cell compartment, appearing instead within the red pulp. CCR7 and its ligands are therefore essential for the normal migration of naïve T cells to the T zones of secondary lymphoid organs.
Maturing dendritic cells also migrate into T zones and the discovery that they upregulate CCR7 and become responsive to ELC and SLC (reviewed in [10] ), together with the finding that SLC is made by lymphatic vessels, led to a seemingly simple model. Immature dendritic cells (for example, Langerhans' cells of the skin) exposed to noxious stimuli in the periphery begin to upregulate CCR7 while endocytosing antigen and then are chemotactically attracted to SLC-expressing lymphatic vessels. Flowing with the lymph, the maturing dendritic cells pour into the subcapsular sinus of the draining node and then follow a gradient of both SLC and ELC to move into the lymphoid T zone.
This notion was tested first in plt mice: Langerhans' cells were indeed found to migrate with reduced efficiency to draining lymph nodes in these mice [2] . Entry of the maturing Langerhans' cells into dermal lymphatics of plt mice was normal, however, which at first did not seem to fit the proposal. But, with the new evidence that plt mice continue to express SLC in peripheral tissues (presumably in the lymphatic vessels) [7] , the model has been resurrected. Further support has now been provided by the finding of an almost complete block in the migration of Langerhans' cells to draining lymph nodes in CCR7-deficient animals [3] . Before this pathway can start appearing in textbooks, however, it remains important to measure directly the number of CCR7-deficient dendritic cells migrating into lymphatic vessels. It will also be interesting to see whether the migration of other types of dendritic cell is affected by the absence of CCR7.
The immunological importance of CCR7 in bringing together antigen-bearing dendritic cells and antigen-specific T cells is supported by the failure of CCR7-deficient mice to mount a delayed-type hypersensitivity response -a form of cell-mediated immunity elicited by antigens in the skin [3] . These mice also mount poor primary antibody responses [3] . Whether this defect is attributable to a role for CCR7 in directing movements of T cells, dendritic cells or B cells, or a combination of these effects has not yet been tested, although other recent findings have established important roles for changes in CCR7 expression in redirecting the movements of helper T cells.
Cells of the Th2 helper T-cell subtype are more effective B-cell helpers than Th1 cells and, in a study published recently in Science, Randolph et al. [11] demonstrate that differences in CCR7 expression may contribute to this differing efficacy. Murine Th2 cells generated in vitro have been found to express low levels of CCR7 and, following in vivo transfer, they migrated to the B-cell-T-cell boundary in the spleen [11] , the site where antigen-specific T and B lymphocytes first interact. Th1 cells, by contrast, express significant amounts of CCR7 and migrate preferentially into the central T zone in the spleen. Strikingly, when the Th2 cells are forced to re-express CCR7 by retrovirusmediated gene transfer, they are redirected towards the central T zone and, importantly, have a reduced ability to act as B-cell helpers [11] . Although the different migratory properties of the Th2 and Th1 cells are less apparent in lymph nodes, other studies suggest that antigen-induced decreases in responsiveness to SLC and ELC may also contribute to T-cell migration towards follicles in lymph nodes [12] . In another recent study, anti-viral CD8 + effector T cells were found to downregulate CCR7 and to lose their ability to enter lymphoid regions of the spleen [13] . Modulation of the levels of CCR7 may therefore be of general importance in redirecting cell movements in lymphoid organs during the immune response.
Low responsiveness to SLC and ELC is also a feature of the memory T-cell population and may act together with reduced expression of the cell-adhesion molecule L-selectin to reduce the homing of memory cells into lymphoid organs and thereby promote migration through peripheral tissues [8, 9] . Some memory T cells do migrate across high endothelial venules into lymph nodes and Peyer's patches [14] , as well as into T-cell areas of the spleen, however [12] . Using a newly generated anti-CCR7 antibody, Sallusto et al. [15] have made the exciting finding that memory T cells in human peripheral blood can be divided into CCR7 + and CCR7 -populations.
CCR7 + memory cells respond to lower doses of antigen than naïve cells and are more efficient at promoting activation of dendritic cells, suggesting that they will be highly effective in initiating the secondary immune response within lymphoid organs. By contrast, a defining feature of the CCR7 -memory cells is their propensity to make large amounts of inflammatory mediators, leading to the suggestion that they are 'memory effector' cells [15] -memory cells that preferentially migrate into peripheral tissues and mediate effector functions. A possible precursor-product relationship between CCR7 + and CCR7 -memory cells is proposed [15] . These provocative findings help to bring together a lot of somewhat discordant data on memory T-cell migration. But memory T cells express receptors for many different chemokines [15] and the discovery that secondary antibody responses are normal in CCR7-deficient mice suggests that memory cells can enter lymph nodes efficiently even in the absence of CCR7. It will therefore be especially important to assess the effect of CCR7 deficiency on the trafficking properties of memory T cells.
In summary, CCR7 and its ligands can now be said conclusively to be required for normal trafficking of T lymphocytes and dendritic cells to lymphoid T zones. Many questions remain, however. Foremost is the issue of the relative roles of SLC and ELC: for example, is ELC needed because cells become desensitized to SLC in the process of crossing high endothelial venules or lymphatic vessels? Given that lymph nodes of plt mice and CCR7-deficient mice have an increased proportion of memory cells relative to naïve cells, does this mean that SLC is not critical for memory cell migration into lymph nodes via afferent lymphatic vessels or high endothelial venules? A role for ELC/SLC and CCR7 in directing movement of B cells to the T zone is supported by studies of the CCR7-deficient animals [3] , but is this role functionally important? Both SLC and ELC are expressed in the thymus and CCR7 expression is increased on thymocytes as they mature [4, 5] . Is the skewed ratio of CD4:CD8 single-positive mature T cells in the peripheral blood of CCR7-deficient animals [3] a hint of a thymic defect? Although ELC and SLC are predominantly lymphoid chemokines, ELC can become upregulated in atherosclerotic lesions [16] . What roles do these molecules play at these and other sites of inflammation?
Although there are a lot of questions still to be answered, the importance of CCR7 and its ligands in bringing multiple cell types together for the immune response is no longer in doubt. So, will a CCR7 antagonist be the next billion dollar molecule?
